S. Branchoux

发表

P0747 : Health related quality of life and utility values in chronic hepatitis C patients: A cross-sectional study in France, the Uk and Germany

S. Pol, G. Milligan, A. Gaudin, 2015 .

Prescription of compression stockings in France in primary care

S. Branchoux, M. Toussi, J. Benigni, 2014, Phlebology.

Immune-checkpoint inhibitors and candidate surrogate endpoints for overall survival across tumour types: A systematic literature review.

A. Italiano, V. Rondeau, Denis Rustand, 2019, Critical reviews in oncology/hematology.

Time to next treatment or death as a candidate surrogate endpoint for overall survival in advanced melanoma patients treated with immune checkpoint inhibitors: an insight from the phase III CheckMate 067 trial

A. Italiano, V. Rondeau, C. Bellera, 2021, ESMO open.

Population characteristics, management, and survival outcomes in muscle-invasive urothelial carcinoma undergoing radical resection: the MINOTAUR study

M. Rouprêt, C. Bellera, A. Gaudin, 2023, World journal of urology.

Atopic dermatitis burden scale: creation of a specific burden questionnaire for families

C. Bodemer, N. Perez-Cullell, S. Branchoux, 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.

The burden of osteoarthritis: development and validation of a new assessment tool (BONe’S)

F. Rannou, S. Branchoux, P. Bertin, 2014, Current medical research and opinion.

Smoking and Dietary Factors Associated with Moderate-to-Severe Acne in French Adolescents and Young Adults: Results of a Survey Using a Representative Sample

P. Wolkenstein, J. Voisard, S. Branchoux, 2014, Dermatology.

Population characteristics, management, and survival outcomes in muscle-invasive urothelial carcinoma undergoing radical resection: the MINOTAUR study

M. Rouprêt, C. Bellera, A. Gaudin, 2023, World Journal of Urology.

A Review of Overall Survival Extrapolations of Immune-Checkpoint Inhibitors Used in Health Technology Assessments by the French Health Authorities

J. Borrill, S. Roze, A. Gaudin, 2022, International Journal of Technology Assessment in Health Care.

Challenges in conducting fractional polynomial and standard parametric network meta-analyses of immune checkpoint inhibitors for first-line advanced renal cell carcinoma

B. McGregor, F. Ejzykowicz, M. Dyer, 2023, Journal of comparative effectiveness research.

PCN42 Real-World Effectiveness in Previously Untreated, Advanced/Metastatic Renal Cell Carcinoma – a Systematic Literature Review Update

S. Ho, F. Ejzykowicz, B. Malcolm, 2020 .

A Comparison of Alternative Network Meta-Analysis Methods in the Presence of Non-Proportional Hazards: A Case Study in First-Line Advanced or Metastatic Renal Cell Carcinoma.

H. Campbell, J. Borrill, S. Branchoux, 2022, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Difficulty Associated with Donning Medical Compression Stockings: Results from a Survey Comparing Two Different Compression Stockings

S. Branchoux, J. Benigni, C. Taieb, 2013, Women's health.

PCN214 COST-EFFECTIVENESS ANALYSIS OF NIVOLUMAB IN COMBINATION WITH IPILIMUMAB VERSUS SUNITINIB FOR THE FIRST-LINE TREATMENT OF INTERMEDIATE- TO POOR-RISK ADVANCED RENAL CELL CARCINOMA IN FRANCE

B. Malcolm, S. Branchoux, S. Négrier, 2019, Value in Health.

Real-World Treatment Patterns and Effectiveness of Patients With Advanced Renal Cell Carcinoma: A Nationwide Observational Study.

A. Gaudin, S. Branchoux, A. Gouverneur, 2023, Clinical genitourinary cancer.